Investors Agree With Trump: Any Trade War

by
China to shut its consulate in Houston within 72 hours

Gold Silver Reports (GSR) – That’s the early view from financial markets as the tariff dust-up between China and the U.S. shows increasing signs of impacting stock prices. While broad measures of American equities have held up better than their Chinese counterparts, striation within the U.S. market shows investors anticipate steep losses in some stalwart names.

Read More →

Cipla Rises On U.S. FDA Nod For Immunodeficiency Drug

by

Neal Bhai Reports (NBR) — Cipla Rises On U.S. FDA Nod For Immunodeficiency Drug – Shares of the Mumbai-based drugmaker rose as much as 6.47 percent to Rs 622.75 after U.S. FDA gave its final approval to Efavirenz tablets in strength of 600 mg. Efavirenz Tablets 600 mg is AB-rated generic therapeutic equivalent version of Bristol-Myers Squibb Pharma Company’s Sustiva which is used in treatment of human immunodeficiency virus type 1 infection, Cipla said in an exchange filing.

Read More →